REDAPT Revision System Study to Assess 5 Year Revision Rate & up to 10 Year Revision Rate and Safety and Effectiveness
Withdrawn before enrolling
Conditions studied: Total Hip Arthroplasty (THA)
In brief
The objective of the study is to demonstrate non-inferiority of stem revision rate in subjects implanted with the REDAPT™ System with a revision rate of less than 9.8% at the 5 year mark assuming an observed rate of 6.5% at 5 years. Additional data will be collected as outcomes of safety and effectiveness data up to 10 years post REDAPT revision surgery.
Key facts
- Study ID
- NCT02344160
- Run by
- Smith & Nephew, Inc.
- People needed
- 0
- Starts
- 2014-12-01
- Expected to finish
- 2028-12-01
- Last updated by the study team
- 2016-12-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subject requires revision hip arthroplasty
- Subject requires subsequent revision of a joint replacement that involves the insertion, removal and/or replacement of a prosthesis or implant
- Subjects with inflammatory degenerative joint disease including rheumatoid arthritis, arthritis secondary to a variety of diseases and anomalies, and congenital dysplasia; non-inflammatory degenerative joint disease (NIDJD) or any of its composite diagnoses of osteoarthritis, avascular necrosis, traumatic arthritis, slipped capital epiphysis, fused hip, fracture of the pelvis, and diastrophic variant
- Treatments of nonunion, femoral neck fracture and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques
- Endoprosthesis, femoral osteotomy, or Girdlestone resection
- Subject is at least 18 years of age
- Subject is skeletally mature in Investigators judgment
- Subject is willing to consent to participate in the study
- Subject is in stable health and is free of or treated and stabilized for cardiac, pulmonary, hematological, infection, or other conditions that would pose excessive operative risk
You may not qualify if…
- Known allergies to any components of the devices
- Subject is entered in another investigational drug, biologic, or device study within 30 days of active study participation
- Subject is known to be at risk for lost to follow-up, or failure to return for scheduled visits
- Subject is facing current or impending incarceration
- Female subject is of child-bearing age and not using an approved method of contraception
- Mental or neurological conditions which could impair the subject's ability or willingness to comply with the study
- Physical conditions or activities which tend to place extreme loads on implants, e.g., Charcot joints, muscle deficiencies, multiple joint disabilities, etc.
- Skeletal immaturity
- Subject is severely overweight (BMI > 40)
Where it is running
- Ran Schwarzkopf — Irvine, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.